Markets›Health care›ABT

Abbott Laboratories

ABT
101.29
+0.22 (+0.22%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value175.27B
Enterprise value202.51B
Price to earnings (P/E)28.3
Price to sales3.9
Price to book3.4
Enterprise value to EBITDA22.1
Free cash flow yield4.2%

Profitability (last 12 months)

Revenue45.13B
Net income6.28B
Gross margin56.3%
Operating margin17.1%
Net margin13.9%
Return on equity12.1%
Return on assets5.7%

Growth (last fiscal year, FY 2025)

Revenue growth+5.7%
EPS growth-51.3%

Balance sheet (latest quarter)

Cash and equivalents6.80B
Total debt34.05B
Debt to equity0.65
Current ratio1.39

Per share and dividends

EPS, diluted (last 12 months)3.58
Shares outstanding1.74B
Dividends paid (last 12 months)None

Trading

Price101.29
52-week high135.45
52-week low81.97
1-year price change-23.91%
Average volume (3 months)9.85M
Beta against the S&P 500 (1 year)0.03

Calculated from Abbott Laboratories's SEC filings (latest quarter ending Mar 31, 2026) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.